Tumor-infiltrating immune cell profiles and changes associate with additional trastuzumab in preoperative chemotherapy for patients with HER2-positive gastric cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Tumor-infiltrating immune cell profiles and changes associate with additional trastuzumab in preoperative chemotherapy for patients with HER2-positive gastric cancer ; volume:131 ; number:9 ; day:23 ; month:9 ; year:2024 ; pages:1463-1472 ; date:11.2024
British journal of cancer ; 131, Heft 9 (23.9.2024), 1463-1472, 11.2024
- Urheber
-
Chen, Cong
Han, Jing
He, Qifei
Yao, Qian
Wang, Xueying
Peng, Zuofu
Sun, Yu
Ji, Jiafu
Xing, Xiaofang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-024-02835-z
- URN
-
urn:nbn:de:101:1-2501172136593.736720143158
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Cong
- Han, Jing
- He, Qifei
- Yao, Qian
- Wang, Xueying
- Peng, Zuofu
- Sun, Yu
- Ji, Jiafu
- Xing, Xiaofang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
Quantifying tumor-infiltrating immune cells from transcriptomics data
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Characterization of tumor-infiltrating B cells in solid tumors
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
Quantifying tumor-infiltrating immune cells from transcriptomics data
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Characterization of tumor-infiltrating B cells in solid tumors
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
Quantifying tumor-infiltrating immune cells from transcriptomics data
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Characterization of tumor-infiltrating B cells in solid tumors
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth